Malignant Neoplasm of Stomach Withdrawn Phase 2 Trials for Pembrolizumab (DB09037)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02943603A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and StomachTreatment